KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment

• Nicola Normanno ,

  * E-mail: nicnorm@yahoo.com

  Affiliations Cell Biology and Biotherapy Unit, INT Fondazione “G. Pascale”, Naples, Italy, Pharmacogenomic Laboratory, CROM – Centro Ricerche Oncologiche di Mercogliano, Avellino, Italy

  ⨯
• Carmine Pinto,

  Affiliation Medical Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy

  ⨯
• Francesca Castiglione,

  Affiliation Department of Human Pathology and Oncology, University of Florence, Florence, Italy

  ⨯
• Alberto Bardelli,

  Affiliation Institute for Cancer Research and Treatment, Università di Torino, Torino, Italy

  ⨯
• Marcello Gambacorta,

  Affiliation Division of Pathology, Ospedale Niguarda Ca' Granda, Milan, Italy

  ⨯
• Gerardo Botti,

  Affiliation Surgical Pathology Unit, INT Fondazione “G. Pascale”, Naples, Italy

  ⨯
• Oscar Nappi,

  Affiliation Surgical Pathology and Cytopathology, Antonio Cardarelli Hospital, Naples, Italy

  ⨯
• Salvatore Siena,

  Affiliation The Falck Division of Medical Oncology, Department of Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy

  ⨯
• Fortunato Ciardiello,

  Affiliation Medical Oncology, Department of Experimental and Clinical Medicine and Surgery F. Magrassi and A. Lanzara, Second University of Naples, Naples, Italy

  ⨯
• GianLuigi Taddei,

  Affiliation Department of Human Pathology and Oncology, University of Florence, Florence, Italy

  ⨯
• Antonio Marchetti

  Affiliation Center of Predictive Molecular Medicine, Center of Excellence on Aging, University-Foundation, Chieti, Italy

  ⨯